| Name: | Acarbose EP Impurity E |
| Catalogue No. | VL5070006 |
| CAS No. | 1220983-28-7 |
| Molecular Formula | C31H53NO23 |
| Molecular Weight | 807.76 |
| Status | Under Development |
| IUPAC Name | 4-((5-(((2R,3R,4R,5S,6R)-5-(((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-(hydroxymethyl)tetrahydro-2H-pyran-2,3,5-triol |
| Description | Acarbose EP Impurity E (CAS No: 1220983-28-7) is an impurity present in Acarbose that is an oral alpha-glucosidase inhibitor and clinically useful drug for the treatment of non-insulin-dependent diabetes mellitus. |
| References | Wang, Ya-Jun, et al. “Analysis and Determination of Anti-Diabetes Drug Acarbose and Its Structural Analogs.” Current Pharmaceutical Analysis, vol. 7, no. 1, Feb. 2011, pp. 12–20, https://doi.org/10.2174/157341211794708721. |
